LINISTAIN SLS— 510(k) K890984

Substantially Equivalent

Shandon, Inc.

FDA 510(k) clearance K890984 for LINISTAIN SLS, Substantially Equivalent on 1989-04-04. Applicant: Shandon, Inc.. Device class: 1.

Clearance details

Applicant
Shandon, Inc.
Product code
Code KIO
Device class
Class 1
Regulation
21 CFR 864.3800
Advisory panel
Pathology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Pittsburgh, PA, US
Download summary PDFView on FDA.gov ↗

More clearances from Shandon, Inc.

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.